Transcutaneous Computed Bioconductance Measurement in Lung Cancer: A Treatment Enabling Technology Useful for Adjunctive Risk Stratification in the Evaluation of Suspicious Pulmonary Lesions Rex C. Yung, MD, Ming Ying Zeng, MD, Gregory J. Stoddard, MS, Michael Garff, BS, Karleen Callahan, PhD Journal of Thoracic Oncology Volume 7, Issue 4, Pages 681-689 (April 2012) DOI: 10.1097/JTO.0b013e31824a8dcd Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions
Figure 1 Freshmedx Bioconductance Scan Platform. Journal of Thoracic Oncology 2012 7, 681-689DOI: (10.1097/JTO.0b013e31824a8dcd) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions
Figure 2 Patient computerized bioconductance test results. Journal of Thoracic Oncology 2012 7, 681-689DOI: (10.1097/JTO.0b013e31824a8dcd) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions
Figure 3 Computed tomography of a patient with a small lesion that pathology showed to be a moderately differentiated (G2) squamous cell carcinoma with a stage of T1N0Mx. Journal of Thoracic Oncology 2012 7, 681-689DOI: (10.1097/JTO.0b013e31824a8dcd) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions
Figure 4 Panels A, B and C show computed tomography images of a patient with a small moderately differentiated (G2) adenocarcinoma with bronchoalveolar features. This patient was staged as T1N0M0. Journal of Thoracic Oncology 2012 7, 681-689DOI: (10.1097/JTO.0b013e31824a8dcd) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions
Figure 5 Receiver operating characteristic performance of the computed bioconductance test. Journal of Thoracic Oncology 2012 7, 681-689DOI: (10.1097/JTO.0b013e31824a8dcd) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions